234 related articles for article (PubMed ID: 8865866)
21. Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane.
Mortier S; Faict D; Schalkwijk CG; Lameire NH; De Vriese AS
Kidney Int; 2004 Sep; 66(3):1257-65. PubMed ID: 15327425
[TBL] [Abstract][Full Text] [Related]
22. Peritoneal dialysis fluid bioincompatibility and new vessel formation promote leukocyte-endothelium interactions in a chronic rat model for peritoneal dialysis.
Schilte MN; Fabbrini P; Wee PM; Keuning ED; Zareie M; Tangelder GJ; Van Lambalgen AA; Beelen RH; Van Den Born J
Microcirculation; 2010 May; 17(4):271-80. PubMed ID: 20536740
[TBL] [Abstract][Full Text] [Related]
23. Peritoneal dialysis solutions disturb the balance of apoptosis and proliferation of peritoneal cells in chronic dialysis model.
Zheng Z; Ye R; Yu X; Bergström J; Lindholm B
Adv Perit Dial; 2001; 17():53-7. PubMed ID: 11510297
[TBL] [Abstract][Full Text] [Related]
24. Glucose suppresses peritoneal inflammatory reactions and mesothelial hyperplasia caused by intraperitoneal saline infusion.
Styszynski A; Podkowka R; Wieczorowska-Tobis K; Kwiatkowska B; Ksiazek K; Breborowicz A; Oreopoulos DG
Adv Perit Dial; 2002; 18():21-5. PubMed ID: 12402581
[TBL] [Abstract][Full Text] [Related]
25. Peritoneal changes after exposure to sterile solutions by catheter.
Flessner MF; Credit K; Henderson K; Vanpelt HM; Potter R; He Z; Henegar J; Robert B
J Am Soc Nephrol; 2007 Aug; 18(8):2294-302. PubMed ID: 17599969
[TBL] [Abstract][Full Text] [Related]
26. Reproducibility of peritoneal equilibration test (PET) in rats.
Wieczorowska K; Khanna R; Moore HL; Nolph KD; Twardowski ZJ
Adv Perit Dial; 1994; 10():33-7. PubMed ID: 7999859
[TBL] [Abstract][Full Text] [Related]
27. Intraperitoneal enalapril ameliorates morphologic changes induced by hypertonic peritoneal dialysis solutions in rat peritoneum.
Duman S; Wieczorowska-Tobis K; Styszynski A; Kwiatkowska B; Breborowicz A; Oreopoulos DG
Adv Perit Dial; 2004; 20():31-6. PubMed ID: 15384791
[TBL] [Abstract][Full Text] [Related]
28. Effects of bicarbonate/lactate solution on peritoneal advanced glycosylation end-product accumulation.
Park MS; Kim JK; Holmes C; Weiss MF
Perit Dial Int; 2000; 20 Suppl 5():S33-8. PubMed ID: 11229610
[TBL] [Abstract][Full Text] [Related]
29. Acute effects of peritoneal dialysis solutions in the mesenteric microcirculation.
Frajewicki V; Brod V; Kushnir D; Kohan R; Bitterman H
Transl Res; 2009 May; 153(5):249-56. PubMed ID: 19375686
[TBL] [Abstract][Full Text] [Related]
30. Dialysis solution containing hyaluronan: effect on peritoneal permeability and inflammation in rats.
Połubinska A; Pawlaczyk K; Kuzlan-Pawlaczyk M; Wieczorowska-Tobis K; Chen C; Moberly JB; Martis L; Breborowicz A; Oreopoulos DG
Kidney Int; 2000 Mar; 57(3):1182-9. PubMed ID: 10720971
[TBL] [Abstract][Full Text] [Related]
31. Functional and structural alterations of peritoneum and secretion of fibrotic cytokines in rats caused by high glucose peritoneal dialysis solutions.
Liu Y; Li JF; Liu H; Liu FY; Peng YM; Liu YH; Cheng MC; Chen GC; Zhou X
Ren Fail; 2014 Mar; 36(2):292-9. PubMed ID: 24152223
[TBL] [Abstract][Full Text] [Related]
32. L-2-oxothiazolidine-4-carboxylate: an agent that modulates lipopolysaccharide-induced peritonitis in rats.
Korybalska K; Wieczorowska-Tobis K; Polubinska A; Wisniewska J; Moberly J; Martis L; Breborowicz A; Oreopoulos DG
Perit Dial Int; 2002; 22(3):293-300. PubMed ID: 12227385
[TBL] [Abstract][Full Text] [Related]
33. Usefulness of the dialysis adequacy and transport test in peritoneal dialysis.
Seo JJ; Kim YL; Park SH; Kim CD; Kim JC; Jang MH; Choi HJ
Adv Perit Dial; 2005; 21():25-30. PubMed ID: 16686280
[TBL] [Abstract][Full Text] [Related]
34. Amphotericin B does not increase peritoneal fluid removal.
Wang T; Heimbürger O; Cheng HH; Bergström J; Lindholm B
Adv Perit Dial; 1998; 14():3-10. PubMed ID: 10649681
[TBL] [Abstract][Full Text] [Related]
35. Rosiglitazone, a peroxisome proliferator-activated receptor agonist, improves peritoneal alterations resulting from an encapsulated peritoneal sclerosis model.
Bozkurt D; Taskin H; Sezak M; Biçak S; Sen S; Ok E; Duman S
Adv Perit Dial; 2008; 24():32-8. PubMed ID: 18985998
[TBL] [Abstract][Full Text] [Related]
36. In vivo model to study the biocompatibility of peritoneal dialysis solutions.
Wieczorowska-Tobis K; Korybalska K; Polubinska A; Radkowski M; Breborowicz A; Oreopoulos DG
Int J Artif Organs; 1997 Dec; 20(12):673-7. PubMed ID: 9506780
[TBL] [Abstract][Full Text] [Related]
37. Comparison of peritoneal equilibration test with 2.27% and 3.86% glucose dialysis solution.
Cara M; Virga G; Mastrosimone S; Girotto A; Rossi V; D'Angelo A; Bonfante L
J Nephrol; 2005; 18(1):67-71. PubMed ID: 15772925
[TBL] [Abstract][Full Text] [Related]
38. Multidirectional approach to study peritoneal dialysis fluid biocompatibility in a chronic peritoneal dialysis model in the rat.
Wieczorowska-Tobis K; Polubinska A; Wisniewska J; Pawlaczyk K; Kuzlan-Pawlaczyk M; Filas V; Breborowicz A; Oreopoulos DG
Nephrol Dial Transplant; 2001 Mar; 16(3):655-6. PubMed ID: 11239060
[TBL] [Abstract][Full Text] [Related]
39. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
[TBL] [Abstract][Full Text] [Related]
40. [Measuring the thickness of the peritoneum as a dialysis membrane using various osmolar concentrations of dialysis fluid].
Korten G
Z Urol Nephrol; 1990 Aug; 83(8):459-63. PubMed ID: 2238886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
